FDA's Post-Approval Drug Tracking Not Reliable, GAO Says
The U.S. Food and Drug Administration doesn't reliably track post-approval safety issues with drugs cleared along expedited pathways, according to a Government Accountability Office report issued Thursday....To view the full article, register now.
Already a subscriber? Click here to view full article